Citius Pharmaceuticals, Inc. - 10 Sep 2025 SCHEDULE 13D/A Report for Citius Oncology, Inc. Common Shares, $0.0001 par value per share (CTOR)

Filing Manager: Citius Pharmaceuticals, Inc.
Reporting Manager: Citius Pharmaceuticals, Inc.
Security: Citius Oncology, Inc. Common Shares, $0.0001 par value per share
Symbol: CTOR
Shares outstanding: 83,501,410 shares
Disclosed Ownership: 66,049,615 shares
Ownership: 79%
Form type: SCHEDULE 13D/A
Filing time: 12 Sep 2025, 16:15:08 UTC
Date of event: 10 Sep 2025
Previous filing: 25 Jul 2025
Next filing: 17 Dec 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Citius Pharmaceuticals, Inc.	79%	66,049,615	66,049,615	0	/s/ Leonard Mazur	Leonard Mazur, Chief Executive Officer	0001506251